Oyora
Who owns Oyora?
Oyora is currently owned by Warburg Pincus.
Hand-verified · updated 2026-04-21
More from Warburg Pincus Other Investments
Other portfolio companies in the same fund.
About Oyora
oyora GmbH is a Berlin-headquartered outpatient healthcare platform covering diagnostic imaging, nuclear medicine, and radiotherapy, delivered through a network of outpatient centers and hospital partnerships across Germany. Warburg Pincus describes it as a leading platform in the German diagnostic imaging market, and trade publication gesundheitsmarkt.de ranked it fifth among German radiology MVZ groups in 2024, when it counted 22 locations across five federal states. The company's own site now lists 32 locations, roughly 910 employees, and 63 cross-sectional imaging systems, with regional clusters ranging from Schleswig-Holstein and Hamburg to the Rhein-Neckar area and southern Baden.
Ownership journey
oyora is a sponsor-built buy-and-build platform rather than a legacy operating company. Warburg Pincus dates its investment to 2021, and the Berlin umbrella company has existed since 2022 under founding CEO Tobias Finn. The platform consolidated long-established regional practice groups: in 2022 Warburg Pincus acquired a majority stake in MVZ Pruener Gang GmbH, a Schleswig-Holstein radiology, nuclear medicine, and radiotherapy network with more than three decades of operating history, a transaction notified to the German competition authority. Warburg Pincus continues to list oyora as a current portfolio company, with no exit to date.
Under PE ownership
Under Warburg Pincus ownership, oyora has executed a sustained roll-up of German radiology groups, folding in MVZ Pruener Gang, with seven sites across Kiel, Flensburg, Rendsburg, Neumuenster, and Damp, and the MVZ DRZ group, whose sites in Heidelberg, Walldorf, Sinsheim, Eberbach, and Erbach operate under the oyora group. From 22 locations across five federal states reported in 2024, the network has grown to 32 locations listed on the company site, with roughly 910 employees and 63 cross-sectional imaging systems. The group has institutionalized the consolidation effort with dedicated heads of M&A and post-merger integration, North and South regional cluster leadership, and a medical advisory board.